Switch to:
Pfizer Inc  (NYSE:PFE) Accounts Receivable: \$9,476 Mil (As of Jun. 2017)

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Pfizer Inc's accounts receivables for the quarter that ended in Jun. 2017 was \$9,476 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Pfizer Inc's Days Sales Outstanding for the quarter that ended in Jun. 2017 was 67.05.

In Ben Graham's calculation of liquidation value, accounts receivable are only considered to be worth 75% of book value. Pfizer Inc's Net-Net Working Capital for the quarter that ended in Jun. 2017 was \$-84,958 Mil.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Pfizer Inc Annual Data

 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Accounts Receivable 10,675.00 9,357.00 8,401.00 8,176.00 8,225.00

Pfizer Inc Quarterly Data

 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Accounts Receivable 9,138.00 9,836.00 8,225.00 8,892.00 9,476.00

Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Pfizer Inc's Days Sales Outstanding for the quarter that ended in Jun. 2017 is calculated as:

 Days Sales Outstanding = Accounts Receivable / Revenue * Days in Period = 9476 / 12896 * 91 = 67.05

2. In Ben Graham's calculation of liquidation value, Pfizer Inc's accounts receivable are only considered to be worth 75% of book value:

Pfizer Inc's liquidation value for the quarter that ended in Jun. 2017 is calculated as:

 Liquidation value = Cash And Cash Equivalents - Total Liabilities + (0.75 * Accounts Receivable) + (0.5 * Total Inventories) = 14333 - 110190 + 0.75 * 9476 + 0.5 * 7584 = -84,958

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Related Terms

From the Internet

###### Aerie (AERI) Up on FDA Review Committee Result for Rhopressa

- Zacks 2017-10-17 16:59:00

###### Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks

- Zacks 2017-10-17 14:55:00

###### 3 Dividend Healthcare Stocks

- Fool 2017-10-17 10:00:00

###### J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales

- Zacks 2017-10-17 09:37:00

###### 3 Things Biotech Learn Today October 17 2017

- Seekingalpha 2017-10-17 09:00:24

###### Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen

- Zacks 2017-10-17 08:44:00

###### Dow Powers to New Record, Nears 23,000

- theStreet 2017-10-16 16:40:00

###### Records for Wall Street as Apple Gains Offset Healthcare Slide

- theStreet 2017-10-16 16:12:00

###### Pharma Industry Outlook - October 2017

- Zacks 2017-10-16 14:59:00

###### Believe Hype

- Seekingalpha 2017-10-16 11:26:05

###### These stocks have popped more than 75% since Trump was elected

- MarketWatch 2017-10-16 10:58:00

###### J&J's Psoriasis Drug Stelara Gets FDA Nod for Adolescent Use

- Zacks 2017-10-16 08:38:00

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)